Disparate effects of angiotensin II antagonists and calcium channel blockers on albuminuria in experimental diabetes and hypertension: potential role of nephrin

被引:58
作者
Davis, BJ
Cao, ZM
de Gasparo, M
Kawachi, H
Cooper, ME
Allen, TJ
机构
[1] Niigata Univ, Sch Med, Inst Nephrol, Dept Cell Biol, Niigata 9518510, Japan
[2] MG Consulting Co, CH-2842 Rossemaison, Switzerland
[3] Univ Melbourne, Dept Med, Heidelberg, Vic 3081, Australia
关键词
albuminuria; angiotensin II; angiotensin receptor antagonist; calcium channel blocker; diabetic nephropathy; nephrin; telemetry;
D O I
10.1097/00004872-200301000-00031
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective and design To explore the effects of various antihypertensive regimes which achieve similar blood pressure control using a range of agents including the angiotensin II type 1 receptor antagonist, valsartan, as monotherapy or in combination with two subclasses of calcium channel blockers (CCBs) (the dihydropyridine, amlodipine and the phenylalkylamine, verapamil) on the progression of renal disease and the expression of the podocyte slit pore protein, nephrin in an accelerated model of diabetic nephropathy. Results Valsartan treatment reduced systolic blood pressure as assessed by radiotelemetry (135 +/- 3 versus diabetic 153 +/- 6 mmHg) as well as retarding the increase in albumin excretion rate by approximately 50%. Combination therapy of valsartan with either amlodipine or verapamil was equally effective in reducing blood pressure to valsartan monotherapy (valsartan + amlodipine 129 +/- 4 valsartan + verapamil 133 +/- 6 mmHg;) but was not as effective at reducing albuminuria. A reduction in glomerulosclerosis was observed with valsartan monotherapy with less reduction in injury with the valsartan + amlodipine combination, despite a similar reduction in blood pressure. The decrease in nephrin, in diabetic rats was attenuated by valsartan monotherapy, but not by other treatments. Conclusions The results of this study demonstrate that despite a similar reduction in blood pressure, the addition of the CCB amlodipine to the All antagonist failed to provide similar renoprotection to that observed with an equihypotensive regimen of valsartan as monotherapy. Furthermore, the depletion in glomerular nephrin expression in diabetic animals was only abrogated by valsartan treatment the therapy which was most effective at retarding the development of albuminuria in this model. (C) 2003 Lippincott Williams Wilkins.
引用
收藏
页码:209 / 216
页数:8
相关论文
共 38 条
[1]  
Agardh CD, 1996, J HUM HYPERTENS, V10, P185
[2]   GLOMERULAR-FILTRATION RATE IN STREPTOZOCIN-INDUCED DIABETIC RATS - ROLE OF EXCHANGEABLE SODIUM, VASOACTIVE HORMONES, AND INSULIN THERAPY [J].
ALLEN, TJ ;
COOPER, ME ;
OBRIEN, RC ;
BACH, LA ;
JACKSON, B ;
JERUMS, G .
DIABETES, 1990, 39 (10) :1182-1190
[3]   Role of angiotensin II and bradykinin in experimental diabetic nephropathy - Functional and structural studies [J].
Allen, TJ ;
Cao, ZM ;
Youssef, S ;
Hulthen, UL ;
Cooper, ME .
DIABETES, 1997, 46 (10) :1612-1618
[4]   NIFEDIPINE VERSUS FOSINOPRIL IN UNINEPHRECTOMIZED DIABETIC RATS [J].
ANDERSON, S ;
RENNKE, HG ;
BRENNER, BM ;
ZAYAS, MA ;
LAFFERTY, HM ;
TROY, JL ;
SANDSTROM, DJ .
KIDNEY INTERNATIONAL, 1992, 41 (04) :891-897
[5]   RENAL RENIN-ANGIOTENSIN SYSTEM IN DIABETES - FUNCTIONAL, IMMUNOHISTOCHEMICAL, AND MOLECULAR BIOLOGICAL CORRELATIONS [J].
ANDERSON, S ;
JUNG, FF ;
INGELFINGER, JR .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (04) :F477-F486
[6]  
BAKRIS GL, 1991, J AM SOC NEPHROL, V2, pS21
[7]   Effects of an ACE inhibitor calcium antagonist combination on proteinuria in diabetic nephropathy [J].
Bakris, GL ;
Weir, MR ;
DeQuattro, V ;
McMahon, FG .
KIDNEY INTERNATIONAL, 1998, 54 (04) :1283-1289
[8]   Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy [J].
Bakris, GL ;
Copley, JB ;
Vicknair, N ;
Sadler, R ;
Leurgans, S .
KIDNEY INTERNATIONAL, 1996, 50 (05) :1641-1650
[9]  
Benigni A, 2001, J AM SOC NEPHROL, V12, P941, DOI 10.1681/ASN.V125941
[10]   CONTINUOUS TELEMETRIC BLOOD-PRESSURE MONITORING AND GLOMERULAR INJURY IN THE RAT REMNANT KIDNEY MODEL [J].
BIDANI, AK ;
GRIFFIN, KA ;
PICKEN, M ;
LANSKY, DM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (03) :F391-F398